Parainfluenza Virus Infection of Young Children: Estimates of the Population-Based Burden of Hospitalization

Journal of Pediatrics

Volumn 154, Issue 5, 2009, Pages

  Weinberg, Geoffrey A ^a   Hall, Caroline B ^a   Iwane, Marika K ^b   Poehling, Katherine A ^c   Edwards, Kathryn M ^c   Griffin, Marie R ^c   Staat, Mary Allen ^d   Curns, Aaron T ^b   Erdman, Dean D ^b   Szilagyi, Peter G ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ACUTE RESPIRATORY TRACT DISEASE; ARTICLE; CALCULATION; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FEVER; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFLUENZA VIRUS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS INFECTION; PARENT; POPULATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROAT CULTURE; TURBINATE; VIRUS CULTURE;

ACUTE DISEASE; APNEA; ASTHMA; BRONCHIOLITIS; CHILD, PRESCHOOL; CROUP; FEMALE; FEVER; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; MALE; OXYGEN INHALATION THERAPY; PARAMYXOVIRINAE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; RESPIROVIRUS INFECTIONS; SEASONS; SEPSIS; UNITED STATES;

EID: 64149119175     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.11.034     Document Type: Article

References (42)

1. Hall C.B. Parainfluenza viruses. In: Feigin R.D., Cherry J.D., Demmler G.J., and Kaplan S.L. (Eds). Textbook of pediatric infectious diseases. 5th ed. (2004), Saunders, Philadelphia 2270-2283
2. Wright P.F. Parainfluenza viruses. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. (2005), Churchill Livingstone Elsevier, Philadelphia 1998-2003
3. Counihan M.E., Shay D.K., Holman R.C., Lowther S.A., and Anderson L.J. Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr Infect Dis J 20 (2001) 646-653
4. Weinberg G.A. Parainfluenza viruses: an underappreciated cause of pediatric respiratory morbidity. Pediatr Infect Dis J 25 (2006) 447-448
5. Hall C.B. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344 (2001) 1917-1928
6. Marx A., Torok T.J., Holman R.C., Clarke M.J., and Anderson L.J. Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis 176 (1997) 1423-1427
7. Institute of Medicine. New vaccine development: establishing priorities. Diseases of importance in the United States Volume 1 (1985), National Academy Press, Washington, DC
8. Reed G., Jewett P.H., Thompson J., Tollefson S., and Wright P.F. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J Infect Dis 175 (1997) 807-813
9. Glezen W.P., Frank A.L., Taber L.H., and Kasel J.A. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis 150 (1984) 851-857
10. Glezen W.P., Loda F.A., Clyde Jr. W.A., Senior R.J., Sheaffer C.I., Conley W.G., et al. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr 78 (1971) 397-406
11. Glezen W.P. Morbidity associated with the major respiratory viruses. Pediatr Ann 19 (1990) 535-536 538, 540, passim
12. Denny F.W., Murphy T.F., Clyde Jr. W.A., Collier A.M., and Henderson F.W. Croup: an 11-year study in a pediatric practice. Pediatrics 71 (1983) 871-876
13. Denny F.W., and Clyde Jr. W.A. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr 108 (1986) 635-646
14. Knott A.M., Long C.E., and Hall C.B. Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics. Pediatr Infect Dis J 13 (1994) 269-273
15. Monto A.S. The Tecumseh study of respiratory illness. V. Patterns of infection with the parainfluenzaviruses. Am J Epidemiol 97 (1973) 338-348
16. Forster J., Ihorst G., Rieger C.H., Stephan V., Frank H.D., Gurth H., et al. Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur J Pediatr 163 (2004) 709-716
17. Iwane M.K., Edwards K.M., Szilagyi P.G., Walker F.J., Griffin M.R., Weinberg G.A., et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113 (2004) 1758-1764
18. Griffin M.R., Walker F.J., Iwane M.K., Weinberg G.A., Staat M.A., and Erdman D.D. Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr Infect Dis J 23 (2004) S188-S192
19. Weinberg G.A., Erdman D.D., Edwards K.M., Hall C.B., Walker F.J., Griffin M.R., et al. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis 189 (2004) 706-710
20. Eisenberg K.W., Szilagyi P.G., Fairbrother G., Griffin M.R., Staat M.A., Shone L.P., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 122 (2008) 911-919
21. Mullins J.A., Erdman D.D., Weinberg G.A., Edwards K., Hall C.B., Walker F.J., et al. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis 10 (2004) 700-705
22. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The under-recognized burden of influenza in young children. N Engl J Med 355 (2006) 31-40
23. Miller E.K., Griffin M.R., Edwards K.M., Weinberg G.A., Szilagyi P.G., Staat M.A., et al. Influenza burden for children with asthma. Pediatrics 121 (2008) 1-8
24. Miller E.K., Lu X., Erdman D.D., Poehling K.A., Zhu Y., Griffin M.R., et al. Rhinovirus-associated hospitalizations in young children. J Infect Dis 195 (2007) 773-781
25. Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., Staat M.A., et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 360 (2009) 588-598
26. Fiore A.E., Shay D.K., Haber P., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56 (2007) 1-54
27. Fry A.M., Curns A.T., Harbour K., Hutwagner L., Holman R.C., and Anderson L.J. Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis 43 (2006) 1016-1022
28. Rihkanen H., Ronkko E., Nieminen T., Komsi K.L., Raty R., Saxen H., et al. Respiratory viruses in laryngeal croup of young children. J Pediatr 152 (2008) 661-665
29. Apfalter P., Reischl U., and Hammerschlag M.R. In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?. J Clin Microbiol 43 (2005) 5835-5841
30. Vachon M.L., Dionne N., LeBlanc E., Moisan D., Bergeron M.G., and Boivin G. Human parainfluenza type 4 infections, Canada. Emerg Infect Dis 12 (2006) 1755-1758
31. Lau S.K., To W.K., Tse P.W., Chan A.K., Woo P.C., Tsoi H.W., et al. Human parainfluenza virus 4 outbreak and the role of diagnostic tests. J Clin Microbiol 43 (2005) 4515-4521
32. Homer C.J., Szilagyi P., Rodewald L., Bloom S.R., Greenspan P., Yazdgerdi S., et al. Does quality of care affect rates of hospitalization for childhood asthma?. Pediatrics 98 (1996) 18-23
33. Perrin J.M., Greenspan P., Bloom S.R., Finkelstein D., Yazdgerdi S., Leventhal J.M., et al. Primary care involvement among hospitalized children. Arch Pediatr Adolesc Med 150 (1996) 479-486
34. Bartlett E.J., maro-Carambot E., Surman S.R., Newman J.T., Collins P.L., Murphy B.R., et al. Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys. Vaccine 23 (2005) 4631-4646
35. Belshe R.B., Newman F.K., Tsai T.F., Karron R.A., Reisinger K., Roberton D., et al. Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. J Infect Dis 189 (2004) 462-470
36. Belshe R.B., Newman F.K., Anderson E.L., Wright P.F., Karron R.A., Tollefson S., et al. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. J Infect Dis 190 (2004) 2096-2103
37. Durbin A.P., and Karron R.A. Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines. Clin Infect Dis 37 (2003) 1668-1677
38. Karron R.A., Wright P.F., Hall S.L., Makhene M., Thompson J., Burns B.A., et al. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis 171 (1995) 1107-1114
39. Madhi S.A., Cutland C., Zhu Y., Hackell J.G., Newman F., Blackburn N., et al. Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine 24 (2006) 2432-2439
40. Murphy B.R., and Collins P.L. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics. J Clin Invest 110 (2002) 21-27
41. Nolan S.M., Surman S.R., maro-Carambot E., Collins P.L., Murphy B.R., and Skiadopoulos M.H. Live-attenuated intranasal parainfluenza virus type 2 vaccine candidates developed by reverse genetics containing L polymerase protein mutations imported from heterologous paramyxoviruses. Vaccine 23 (2005) 4765-4774
42. Slobod K.S., Shenep J.L., Lujan-Zilbermann J., Allison K., Brown B., Scroggs R.A., et al. Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults. Vaccine 22 (2004) 3182-3186